Perrigo | PRGO - 销售和管理费用





销售和管理费用 更改 日
AbbVie USD 3.63B 54M 2026-06
Abbott USD 3.6B 330M 2026-06
Bayer EUR 3.7B 356M 2026-03
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Coherus Biosciences USD 15M 6.26M 2025-12
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Dr.Reddys Laboratories INR 26.1B 11.63B 2026-06
Eli Lilly USD 2.93B 198M 2026-03
J&J USD 6.42B 381M 2026-06
Merck USD 2.67B 180M 2026-03
Nestle CHF 12.33B 133M 2026-06
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 267.3M 11.4M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 30.28M 606K 2026-03
Sanofi EUR 2.63B 307M 2026-06
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03
Zoetis USD 588M 31M 2026-03